Special Issue "Targeting CAR T-Cell Therapy: Molecular Research and Its Future Implication"

Stella Bouziana1,2

  • 1Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Medicine, King's College London, London SE5 8AF, UK.

Summary

Chimeric antigen receptor (CAR) T-cell therapy is a groundbreaking cancer treatment. This therapy involves genetically modifying a patient's T-cells to target and destroy cancer cells effectively.

Related Concept Videos